Overexpression and hyperphosphorylation of FAK are associated with many types of solid tumors, which implying that the inhibition of FAK-stimulated tumor metastases by small molecule can provide a novel strategy for the development of therapeutic agents in tumor growth and metastasis7. Here, PTK2 is linked to neoplasm.